Durable response without recurrence to Tolvaptan improves long-term survival

被引:0
|
作者
Masato Nakai
Goki Suda
Akinori Kubo
Yoshimasa Tokuchi
Takashi Kitagataya
Ren Yamada
Taku Shigesawa
Kazuharu Suzuki
Akihisa Nakamura
Naoki Kawagishi
Masatsugu Ohara
Machiko Umemura
Takuya Sho
Kenichi Morikawa
Koji Ogawa
Naoya Sakamoto
机构
[1] Hokkaido University Graduate School of Medicine,Department of Gastroenterology and Hepatology
来源
Journal of Gastroenterology | 2020年 / 55卷
关键词
Tolvaptan; Recurrence; C-reactive protein; Acute kidney injury; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1150 / 1161
页数:11
相关论文
共 50 条
  • [21] OBESITY IMPROVES LONG-TERM SURVIVAL IN PATIENTS WITH ATRIAL FIBRILLATION
    Melduni, Rowlens
    Gersh, Bernard J.
    Jaffe, Allan S.
    Senapati, Sidhartha Gautam
    Noseworthy, Peter
    Lee, Hon-Chi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 132 - 132
  • [22] Centralization of rectal cancer surgery improves long-term survival
    Khani, M. Hosseinali
    Smedh, K.
    COLORECTAL DISEASE, 2010, 12 (09) : 874 - 879
  • [23] Overweight improves long-term survival in Japanese patients with asthma
    Sasaki, Jun
    Kawayama, Tomotaka
    Kinoshita, Takashi
    Matama, Chiyo
    Tsuneyoshi, Shingo
    Yano, Ryo
    Matsuoka, Masanobu
    Hoshino, Tomoaki
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [24] Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma
    Pallotti, Maria Caterina
    Nannini, Margherita
    Agostinelli, Claudio
    Leoni, Simona
    Di Scioscio, Valerio
    Mandrioli, Anna
    Lolli, Cristian
    Saponara, Maristella
    Pileri, Stefano
    Bolondi, Luigi
    Biasco, Guido
    Pantaleo, Maria Abbondanza
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (22) : 7049 - 7054
  • [25] Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma
    Maria Caterina Pallotti
    Margherita Nannini
    Claudio Agostinelli
    Simona Leoni
    Valerio Di Scioscio
    Anna Mandrioli
    Cristian Lolli
    Maristella Saponara
    Stefano Pileri
    Luigi Bolondi
    Guido Biasco
    Maria Abbondanza Pantaleo
    World Journal of Gastroenterology, 2014, 20 (22) : 7049 - 7054
  • [26] Long-term efficacy of tolvaptan therapy in patients with ADPKD
    Geertsema, Paul
    Bais, Thomas
    Kuiken, Vera
    Knol, Martine
    Casteleijn, Niek F.
    Vart, Priya
    Meijer, Esther
    Gansevoort, Ronald
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [27] ARE THE LONG-TERM OUTCOMES OF PPH DURABLE?
    Chong, H.
    Pazin, B.
    Wexner, S.
    da Silva, G.
    Weiss, E.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (04) : E152 - E153
  • [28] Long-term administration of Tolvaptan to patients with decompensated cirrhosis
    Kanayama, Kengo
    Chiba, Tetsuhiro
    Kobayashi, Kazufumi
    Koroki, Keisuke
    Maruta, Susumu
    Kanzaki, Hiroaki
    Kusakabe, Yuko
    Saito, Tomoko
    Kiyono, Soichiro
    Nakamura, Masato
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Nakamoto, Shingo
    Yasui, Shin
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Jun
    Kato, Naoya
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (07): : 874 - 880
  • [29] Long-term Effects of Tolvaptan in Patients with Heart Failure
    Ogawa, Hayato
    Ajioka, Masayoshi
    Otaka, Naoya
    Sakaguchi, Teruhiro
    Nakano, Yoshihisa
    Hara, Akitoshi
    Murase, Yosuke
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S180 - S180
  • [30] Long-term efficacy of tolvaptan therapy in patients with ADPKD
    Geertsema, Paul
    Bais, Thomas
    Kuiken, Vera
    Knol, Martine
    Casteleijn, Niek F.
    Vart, Priya
    Meijer, Esther
    Gansevoort, Ronald
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I421 - I421